https://www.selleckchem.com/pr....oducts/tdi-011536.ht
the UC group (adjusted OR (95% CI)2.28 (1.07, 4.85; p=0.036). A significant difference (p=0.005) in change from baseline in ACT total score was observed in ACT-guided treatment vs. UC group at Week 24. The mean annual exacerbation rate was similar in both the groups. ACT-guided treatment was more effective in achieving ACT total score ≥20 or showing an improvement of 3 points in the ACT total score and well tolerated compared with UC treatment in the 24-week treatment period. Clinical trials.gov Identifier NCT02868281, https//cli
Curtir
Comentario
Compartilhar
